Lupin has launched generic morphine sulfate tablets in US
Lupin, the pharma major has launched its generic version of morphine sulfate ER tablets that are used for management of severe pain. The company has...
Tag : Lupin
Lupin has received USFDA approval to market its skin cream
Lupin has got the US health regulator’s final approval for marketing its Desoximetasone cream that is used in treating skin disease in the American market....
Lupin Outlook for the Week (January 09, 2017 – January 13, 2017)
EquityPandit’s Outlook for Lupin for the week (January 09, 2017 – January 13, 2017) : LUPIN: Lupin closed the week on positive note gaining...
Lupin has received USFDA approval for cevimeline hydrochloride capsules
Lupin has got the US health regulator’s final approval from for marketing cevimeline hydrochloride capsules that are used in treating the symptoms of dry mouth...
Lupin Outlook for the Week (January 02, 2017 – January 06, 2017)
EquityPandit’s Outlook for Lupin for the week (January 02, 2017 – January 06, 2017) : LUPIN: Lupin closed the week on positive note gaining around...
USFDA provides its approval to Lupin to market uclerative colitis tablets in US
The US health regulator has provided its approval to Lupin for marketing its Balasalazide Disodium tablets that are used to treat uclerative colitis, in the...
Lupin has received USFDA approval for hypertension treatment drug in US
Lupin has got US health regulator’s approval to sell Olmesartan medoximil tablets that are used in treating high blood pressure in the American market. Lupin...
Lupin Outlook for the Week (December 26, 2016 – December 30, 2016)
EquityPandit’s Outlook for Lupin for the week (December 26, 2016 – December 30, 2016) : LUPIN: Lupin closed the week on negative note...
Lupin announces launche of voriconazole tablets
Lupin Ltd has announced the launch of generic version of its voriconazole tablets and oral suspension that are used to treat fungal infections in children....
Lupin Outlook for the Week (December 19, 2016 – December 23, 2016)
EquityPandit’s Outlook for Lupin for the week (December 19, 2016 – December 23, 2016) : LUPIN: Lupin closed the week on negative note...